Asset Publisher

Research

VEIS

Leveraging the European Genome-Phenome Archive (EGA) for Industry and Society

Duration
2019-2021
Coordinator
Arcadi Navarro (Universitat Pompeu Fabra)
Funded by
Generalitat de Catalunya and European Regional Development Fund (ERDF)

Valorisation of the EGA for Industry and Society (VEIS) is an initiative of a consortium formed by the Catalan research centres that are home to the main bioinformatics groups currently involved in setting up and leading projects being undertaken to design, evaluate and ultimately implement the infrastructure for clinical settings that will serve as a key resource for the development of personalised medicine. One of these groups is ISGlobal’s Bioinformatic Research Group in Epidemiology (BRGE). The consortium brings together three of the main hospital institutions in the area.

The core mission of VEIS is to create an open ecosystem of technologies—the Barcelona Computational Biomedical Ecosystem (BCBE)—that will address and adapt to the requirements of the systems used to analyse and interpret -omics and clinical data in research and application environments in biomedicine. This ecosystem will be based on Local EGA, the federated implementation of the European archive. The aim of the project—as its name suggests—is to leverage the value of the EGA for both industry and society.

The members of the consortium represent a broad spectrum of knowledge, ranging from basic research to the most translational aspects of routine clinical practice. The work is divided into several interconnected work packages: the design of the necessary functionalities for biomedical research that will be included in the BCBE; the integration and implementation of these functionalities with the framework of the EGA; and their assessment in real-life applications in clinical settings and in the molecular and bioinformatics sectors.

These functionalities will facilitate the identification, interpretation and management of -omics data and associated clinical and molecular data. This project will lay the groundwork for the proposed ecosystem to be used in other research centres in the area. More importantly, it will help to maintain and consolidate Barcelona’s position of international leadership in this field, thanks to the efforts of—and investments made in—the groups and institutions supporting the initiative.

Budget

The VEIS project with file number 001-P-001647 has been co-financed by 50%, with € 1,951,429.38, by the European Regional Development Fund of the European Union within the framework of the ERDF Operational Programme of Catalonia 2014-2020, with the support of the Generalitat de Catalunya. ISGlobal will receive 60,208.46 euros of funding.

Our Team

ISGlobal Team

  • Juan Ramón González Ruiz
    Juan Ramón González Ruiz

Other projects

See Past Projects

MCC-Spain

Population based multicasecontrol study on common tumours in Spain

HELIX

Novel tools for integrating early-life environmental exposures and child health across Europe

EGG/EAGLE

Early Genetics Growth/Early Genetics and Lifecourse Epidemiology

PACE

Pregnancy and Childhood Epigenetics

LIFECYCLE

Early-life stressors and LifeCycle health

OMEGA-NET

Network on the Coordination and Harmonisation of European Occupational Cohorts

HARMONIC

Health effects of cArdiac fluoRoscopy and mOdern radIotherapy in paediatriCs

Mobilise-D

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

EARLY-ADAPT

Signs of Early Adaptation to Climate Change

COVICAT

Cohorte Covid-19 en Cataluña

ATHLETE

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

CONTENT

Cohort of COVID-19 in Spain: social dynamics, mental health and inequalities

EUCAN-Connect

A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health

OBERON

An integrative strategy of testing systems for identification of EDs related to metabolic disorders

EXPANSE

EXposome Powered tools for healthy living in urbAN SEttings

AURORA 2021

Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics

ONES

Fine Particle Matter, Fetal Growth, and Neurodevelopment: Examining Critical Windows of Susceptibility

AIR-NB

Pre-natal exposure to urban AIR pollution and pre- and post-Natal Brain development

NutinBrain

The role of seafood and nut consumption on human neurodevelopment from pregnancy to adolescence

UrbanKids

Urban and social environment and childhood obesity – a natural moving2health experiment

iGenCO

In-Depth Genomics and Cross-Omics Analysis for Undiagnosed Rare Diseases on a User-Friendly Collaborative Platform

CityExposomeCat

An Exposome Approach to Urban Health: Individualized Environmental Exposure Assessment in an Adults Population Cohort Study (GCAT)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

UBDPOLICY

The Urban Burden of Disease Estimation for POLICY Making

TOLIFE

Combining Artificial Intelligence and smart sensing TOward better management and improved quality of LIFE in chronic obstructive pulmonary disease

BWater

Drinking Water in Barcelona: Sustainability and Health Impact Assessment

intoDBP

Innovative Tools to Control Organic Matter and Disinfection Byproducts in Drinking Water

FINDOOR

FTIR spectroscopy for real-time detection of bacterial outbreaks and the rapid identification of pathogenic serotypes, relapsing infections and antibiotic resistance

OccRF-Health

Occupational exposure to radiofrequency electromagnetic fields: From exposure assessment to study of health in workers and their offspring

EPHOR

Exposome Project for Health and Occupational Research

EXPONIT

Analysing and studying how night shift work affects workers' circadian rhythms and health

IHEN

International Human Exposome Network

B-Triage

Una prueba en el punto de atención para la estratificación del riesgo de los pacientes febriles basada en los niveles de sTREM-1

e-QuoL

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families

AM-MENTAL

What happens with your mental health when your supervisor is an algorithm?